These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 19477776)

  • 1. Hot flashes in prostate cancer: state of the science.
    Engstrom CA
    Am J Mens Health; 2008 Jun; 2(2):122-32. PubMed ID: 19477776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between hot flashes and distress in men receiving androgen deprivation therapy for prostate cancer.
    Ulloa EW; Salup R; Patterson SG; Jacobsen PB
    Psychooncology; 2009 Jun; 18(6):598-605. PubMed ID: 18942660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of hot flashes on quality of life in patients with prostate cancer treated with androgen deprivation therapy.
    Nishiyama T; Kanazawa S; Watanabe R; Terunuma M; Takahashi K
    Int J Urol; 2004 Sep; 11(9):735-41. PubMed ID: 15379937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hot flashes during androgen deprivation therapy with luteinizing hormone-releasing hormone agonist combined with steroidal or nonsteroidal antiandrogen for prostate cancer.
    Sakai H; Igawa T; Tsurusaki T; Yura M; Kusaba Y; Hayashi M; Iwasaki S; Hakariya H; Hara T; Kanetake H
    Urology; 2009 Mar; 73(3):635-40. PubMed ID: 19038426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermittent androgen ablation in patients with biochemical failure after pelvic radiotherapy for localized prostate cancer.
    Cury FL; Souhami L; Rajan R; Tanguay S; Gagnon B; Duclos M; Shenouda G; Faria SL; David M; Freeman CR
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):842-8. PubMed ID: 16289909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Andropause syndrome in men treated for metastatic prostate cancer: a qualitative study of the impact of symptoms.
    Grunfeld EA; Halliday A; Martin P; Drudge-Coates L
    Cancer Nurs; 2012; 35(1):63-9. PubMed ID: 21558849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Managing hot flashes in men being treated for prostate cancer.
    Baum NH; Torti DC
    Geriatrics; 2007 Nov; 62(11):18-21. PubMed ID: 17999566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pilot evaluation of venlafaxine for the treatment of hot flashes in men undergoing androgen ablation therapy for prostate cancer.
    Quella SK; Loprinzi CL; Sloan J; Novotny P; Perez EA; Burch PA; Antolak SJ; Pisansky TM
    J Urol; 1999 Jul; 162(1):98-102. PubMed ID: 10379749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hot flash experience in men with prostate cancer: a concept analysis.
    Engstrom C
    Oncol Nurs Forum; 2005 Sep; 32(5):1043-8. PubMed ID: 16136202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circadian rhythm of hot flashes and activity levels among prostate cancer patients on androgen deprivation therapy.
    Hanisch LJ; Gehrman PR
    Aging Male; 2011 Dec; 14(4):243-8. PubMed ID: 21627561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Castration of prostate cancer patients and cognition].
    Portin R; Koskinen A; Helenius H; Nurmi M; Salminen E
    Duodecim; 2005; 121(16):1784-5. PubMed ID: 16268226
    [No Abstract]   [Full Text] [Related]  

  • 12. Incidence and management of gynecomastia in men treated for prostate cancer.
    Dobs A; Darkes MJ
    J Urol; 2005 Nov; 174(5):1737-42. PubMed ID: 16217274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and management of hot flashes in prostate cancer.
    Spetz AC; Zetterlund EL; Varenhorst E; Hammar M
    J Support Oncol; 2003; 1(4):263-6, 269-70, 272-3; discussion 267-8, 271-2. PubMed ID: 15334868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 'You know I've joined your club… I'm the hot flush boy': a qualitative exploration of hot flushes and night sweats in men undergoing androgen deprivation therapy for prostate cancer.
    Eziefula CU; Grunfeld EA; Hunter MS
    Psychooncology; 2013 Dec; 22(12):2823-30. PubMed ID: 23893467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective evaluation of hot flashes during treatment with parenteral estrogen or complete androgen ablation for metastatic carcinoma of the prostate.
    Spetz AC; Hammar M; Lindberg B; Spångberg A; Varenhorst E;
    J Urol; 2001 Aug; 166(2):517-20. PubMed ID: 11458057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Finnish multicenter study comparing intermittent to continuous androgen deprivation for advanced prostate cancer: interim analysis of prognostic markers affecting initial response to androgen deprivation.
    Salonen AJ; Viitanen J; Lundstedt S; Ala-Opas M; Taari K; Tammela TL;
    J Urol; 2008 Sep; 180(3):915-9; discussion 919-20. PubMed ID: 18635219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen deprivation therapy and estrogen deficiency induced adverse effects in the treatment of prostate cancer.
    Freedland SJ; Eastham J; Shore N
    Prostate Cancer Prostatic Dis; 2009; 12(4):333-8. PubMed ID: 19901933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life compared during pharmacological treatments and clinical monitoring for non-localized prostate cancer: a randomized controlled trial.
    Green HJ; Pakenham KI; Headley BC; Yaxley J; Nicol DL; Mactaggart PN; Swanson CE; Watson RB; Gardiner RA
    BJU Int; 2004 May; 93(7):975-9. PubMed ID: 15142146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managing complications of androgen deprivation therapy for prostate cancer.
    Holzbeierlein JM
    Urol Clin North Am; 2006 May; 33(2):181-90, vi. PubMed ID: 16631456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiology and endocrinology of hot flashes in prostate cancer.
    Engstrom CA; Kasper CE
    Am J Mens Health; 2007 Mar; 1(1):8-17. PubMed ID: 19482779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.